Christopher Pechock insider trades: Myos Rens Technology (MYOS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2020 | MYOS | ↑ Buy | 82,645 | $1.21 | $100K | Direct | Mar 9, 2020 (4d) |
| Mar 27, 2019 | MYOS | ↑ Buy | 34,247 | $1.46 | $50K | Direct | Mar 27, 2019 (0d) |
| Apr 25, 2018 | MYOS | ↑ Buy | 80,645 | $1.24 | $100K | Direct | Apr 27, 2018 (2d) |
| Mar 4, 2008 | BPSG | ↑ Buy | 1,594,000 | $1.70 | $2.7M | Indirect | Mar 7, 2008 (3d) |
| Aug 6, 2007 | HUN | ↓ Sell | 56,979,062 | $24.25 | $1.38B | By Matlin Partnerships | Aug 8, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher Pechock's insider trades
Christopher Pechock is a director at Myos Rens Technology (MYOS). Since Aug 6, 2007, Christopher has reported 4 open-market purchases worth $3.0M and 1 sale worth $1.38B on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.